![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 21, 15845-15850, May 26, 2000
From the Mutacin II is a post-translationally modified
lantibiotic peptide secreted by Streptococcus mutans T8,
which inhibits the energy metabolism of sensitive cells. The deduced
amino acid sequence of promutacin II is NRWWQGVVPTVSYECRMNSWQHVFTCC,
which is capable of forming three thioether bridges. It was not
obvious, however, how the three thioether bridges are organized. To
examine the bridging, the cyanogen bromide cleavage products of mutacin
II and its variants generated by protein engineering, C15A, C26A, and
C15A/C26A, were analyzed by mass spectrometry. Analysis of the wild
type molecule and the C15A variant excluded several possibilities and
also indicated a high fidelity of formation of the thioether bridges.
This allowed us to further resolve the structure by analysis (mass
spectrometry and tandem mass spectrometry) of the cyanogen bromide
cleavage fragments of the C26A and C15A/C26A mutants. Nuclear magnetic
resonance analysis established the presence of one and two
dehydrobutyrine residues in mutacin II and the C15A variant,
respectively, thus yielding the final structure. The results of this
investigation showed that the C-terminal part contains three thioether
bridges connecting Cys residues 15, 26, and 27 to Ser/Thr residues 10, 12 and 19, respectively, with Thr25 being modified to dehydrobutyrine.
Biochemical Structural Analysis of the Lantibiotic Mutacin
II*
§¶,
,
,
,
Department of Oral Biology,
§ Department of Biochemistry and Molecular Genetics,
Department of Microbiology, ** Comprehensive Cancer Center, and

Department of Pharmacology and
Toxicology, University of Alabama at Birmingham,
Birmingham, Alabama 35294
*
This work was supported by National Institutes of Health
(NIH) Grant DE09082. The mass spectrometers were purchased by funds from NIH Instrumentation Grants S10RR06487 and S10 and from the University of Alabama at Birmingham (UAB). The operation of the Mass
Spectrometry, Nuclear Magnetic Resonance and Protein Sequencing Shared
Facilities has been supported in part by NCI, NIH, Core Research
Support Grant P30 CA13148 to the UAB Comprehensive Cancer Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
I. F. Nes, D. B. Diep, and H. Holo Bacteriocin Diversity in Streptococcus and Enterococcus J. Bacteriol., February 15, 2007; 189(4): 1189 - 1198. [Full Text] [PDF] |
||||
![]() |
O. Hyink, P. A. Wescombe, M. Upton, N. Ragland, J. P. Burton, and J. R. Tagg Salivaricin A2 and the Novel Lantibiotic Salivaricin B Are Encoded at Adjacent Loci on a 190-Kilobase Transmissible Megaplasmid in the Oral Probiotic Strain Streptococcus salivarius K12 Appl. Envir. Microbiol., February 15, 2007; 73(4): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. He, D. Kisla, L. Zhang, C. Yuan, K. B. Green-Church, and A. E. Yousef Isolation and Identification of a Paenibacillus polymyxa Strain That Coproduces a Novel Lantibiotic and Polymyxin Appl. Envir. Microbiol., January 1, 2007; 73(1): 168 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dabard, C. Bridonneau, C. Phillipe, P. Anglade, D. Molle, M. Nardi, M. Ladire, H. Girardin, F. Marcille, A. Gomez, et al. Ruminococcin A, a New Lantibiotic Produced by a Ruminococcus gnavus Strain Isolated from Human Feces Appl. Envir. Microbiol., September 1, 2001; 67(9): 4111 - 4118. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |